Stay updated with breaking news from View More. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As we step into the year's last quarter, it is worth noting that the FDA has already granted approval to 40 novel drugs in 2023, a significant increase compared to the 26 novel drugs approved during the same period last year.
Below are the earnings highlights for Conagra Brands Inc. (CAG): Earnings: $319.7 million in Q1 vs. -$77.5 million in the same period last year. EPS: $0.67 in Q1 vs.
As we step into the year's last quarter, it is worth noting that the FDA has already granted approval to 40 novel drugs in 2023, a significant increase compared to the 26 novel drugs approved during the same period last year.
Acuity Brands, Inc. (AYI) shares are gaining more than 3 percent on Wednesday morning trade after the company reported a lower fourth-quarter profit, however beat estimates.
Below are the earnings highlights for AngioDynamics Inc. (ANGO): Earnings: $45.884 million in Q1 vs. -$13.004 million in the same period last year. EPS: $1.